Clinical and genetic features of sarcoglycanopathies: results of a Europe-wide collaboration

A European network is helping to establish the clinical and genetic features of sarcoglycanopathies, according to data presented at WMS 2020.

“Sarcoglycanopathies are extremely rare disorders,” said Dr Jorge Alonso-Pérez of the Hospital de la Santa Creu i Sant Pau in Barcelona, Spain. As a group, they are one of the most frequent causes of limb-girdle muscular dystrophy (LGMD).

Mutations in the sarcoglycan genes SGCA, SGCB, SGCG, and SGCD are known to cause LGMDR3, LGMDR4, LGMDR5, and LGMDR6, respectively. “Development of international networks can result in an extended collection of clinical and genetic data that eventually will improve knowledge of this disease.”

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.